Mechanisms of action of brain insulin against neurodegenerative diseases

Journal of Neural Transmission

Volumn 121, Issue 6, 2014, Pages 611-626

  Ramalingam, Mahesh ^a   Kim, Sung Jin ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Brain; Brain signaling pathways; Insulin; Neurodegenerative disease; Neuroprotection

Indexed keywords

ALPHA SYNUCLEIN; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOCHROME C; FORKHEAD TRANSCRIPTION FACTOR; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; RAC1 PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; S6 KINASE; SIRTUIN 1; SOMATOMEDIN C;

ACTIVE TRANSPORT; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN TISSUE; DEGENERATIVE DISEASE; FEEDING BEHAVIOR; HUMAN; HUNTINGTON CHOREA; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; MACROMOLECULE; MEMORY; METABOLISM; NEUROMODULATION; NEUROPROTECTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; NEURODEGENERATIVE DISEASES; PATHOLOGY;

ANIMALS; BRAIN; HUMANS; INSULIN; NEURODEGENERATIVE DISEASES;

EID: 84901835581     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1147-1     Document Type: Review

References (202)

1. Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275(12):9047-9054. doi: 10.1074/jbc.275.12.9047
2. Anton S, Melville L, Rena G (2007) Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19(2):378-383. doi: 10.1016/j.cellsig.2006.07.008
3. Aviles-Olmos I, Limousin P, Lees A, Foltynie T (2013) Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 136(Pt 2):374-384. doi: 10.1093/brain/aws009
4. Bacos K, Bjorkqvist M, Petersen A, Luts L, Maat-Schieman ML, Roos RA, Sundler F, Brundin P, Mulder H, Wierup N (2008) Islet beta-cell area and hormone expression are unaltered in Huntington's disease. Histochem Cell Biol 129(5):623-629. doi: 10.1007/s00418-008-0393-z
5. Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179. doi: 10.1146/annurev.iy.12.040194. 001041
6. Bang S, Steenstra C, Kim SF (2012) Striatum specific protein, Rhes regulates AKT pathway. Neurosci Lett 521(2):142-147. doi: 10.1016/j.neulet.2012. 05.073
7. Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15):1066-1071. doi: 10.1056/NEJM199704103361506
8. Barthel A, Schmoll D, Unterman TG (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16(4):183-189. doi: 10.1016/j.tem.2005. 03.010
9. Baura GD, Foster DM, Porte D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW (1993) Saturable transport of insulin from plasma into the central-nervous- system of dogs in-vivo - a mechanism for regulated insulin delivery to the brain. J Clin Invest 92(4):1824-1830. doi: 10.1172/Jci116773
10. Belka C, Budach W (2002) Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol 78(8):643-658. doi: 10.1080/09553000210137680
11. Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29(10):1326-1334. doi: 10.1016/j.psyneuen.2004.04.003
12. Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL, Born J, Kern W (2007) Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32(1):239-243. doi: 10.1038/sj.npp. 1301193
13. Bolanos JP, Almeida A (2010) The pentose-phosphate pathway in neuronal survival against nitrosative stress. IUBMB Life 62(1):14-18. doi: 10.1002/iub.280
14. Bolanos JP, Heales SJ, Peuchen S, Barker JE, Land JM, Clark JB (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med 21(7):995-1001. doi: 10.1016/S0891-5849(96) 00240-7
15. Bondy CA, Cheng CM (2004) Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 490(1-3):25-31. doi: 10.1016/j.ejphar.2004.02.042
16. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197-211. doi: 10.1016/S0197-4580(02)00065-9
17. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6):857-868. doi: 10.1016/S0092-8674(00)80595-4
18. Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376(6541):599-602. doi: 10.1038/376599a0
19. Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR, van Nostrand W, St George-Hyslop P, Westaway D, Wellington CL (2006) Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma. Neurobiol Dis 24(1):114-127. doi: 10.1016/j.nbd.2006.06.007
20. Camacho-Hubner C, Woods KA, Clark AJ, Savage MO (2002) Insulin-like growth factor (IGF)-I gene deletion. Rev Endocr Metab Disord 3(4):357-361. doi: 10.1023/A:1020957809082
21. Carson MJ, Behringer RR, Brinster RL, McMorris FA (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10(4):729-740. doi: 10.1016/0896-6273(93)90173-O
22. Chan PH (2004) Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 29(11):1943-1949. doi: 10.1007/s11064-004-6869-x
23. Chang YC, Chuang LM (2010) The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res 2(3):316-331. doi: http://www.ncbi.nlm.nih.gov/ pubmed/20589170
24. Chap Z, Ishida T, Chou J, Hartley CJ, Entman ML, Brandenburg D, Jones RH, Field JB (1987) First-pass hepatic extraction and metabolic effects of insulin and insulin analogues. Am J Physiol 252(2 Pt 1):E209-E217
25. Cheng Z, Guo S, Copps K, Dong X, Kollipara R, Rodgers JT, Depinho RA, Puigserver P, White MF (2009) Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 15(11):1307-1311. doi: 10.1038/nm.2049
26. Clarke DW, Mudd L, Boyd FT, Fields M, Raizada MK (1986) Insulin is released from rat brain neuronal cells in culture. J Neurochem 47(3):831-836. doi: 10.1111/j.1471-4159.1986.tb00686.x
27. Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp Gerontol 42(1-2):10-21. doi: 10.1016/j.exger.2006.08.009
28. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res Rev 10(2):264-273. doi: 10.1016/j.arr.2011.01.001
29. Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169-178. doi: 10.1016/S1474-4422(04) 00681-7
30. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50(1):164-168. doi: 10.1212/WNL.50.1.164
31. Craft S, Cholerton B, Baker LD (2013) Insulin and Alzheimer's disease: untangling the web. J Alzheimers Dis 33(Suppl 1):S263-S275. doi: 10.3233/JAD-2012-129042
32. Crowder RJ, Freeman RS (2000) Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275(44):34266-34271. doi: 10.1074/jbc.M006160200
33. Dasgupta A, Pal M, Ghosh T, Roy U, Konar S, Biswas S, Maity C (2013) Differential effects of insulin induced hypoglycaemia upon redox balance in distinct rat brain areas. Orient Pharm Exp Med 13(4):279-287. doi: 10.1007/s13596-013-0111-9
34. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231-241. doi: 10.1016/S0092-8674(00)80405-5
35. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU (2012) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8(2):114-126. doi: 10.1038/nrendo.2011.156
36. de Moura MB, dos Santos LS, Van Houten B (2010) Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen 51(5):391-405. doi: 10.1002/em.20575
37. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE (2005) Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16(4-5):421-439. doi: 10.1016/j.cytogfr.2005.04.004
38. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269(11):8445-8454
39. Dickson DW, Lin W, Liu WK, Yen SH (1999) Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9(4):721-732. doi: 10.1111/j.1750-3639. 1999.tb00553.x
40. Dise RS, Frey MR, Whitehead RH, Polk DB (2008) Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 294(1):G276-G285. doi: 10.1152/ajpgi.00340.2007
41. Downward J (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10(2):262-267. doi: 10.1016/S0955-0674(98) 80149-X
42. Du H, Yan SS (2010) Mitochondrial medicine for neurodegenerative diseases. Int J Biochem Cell Biol 42(5):560-572. doi: 10.1016/j.biocel.2010.01. 004
43. Duan C (2002) Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J Endocrinol 175(1):41-54. doi: 10.1677/joe.0.1750041
44. Duarte AI, Santos MS, Oliveira CR, Rego AC (2005) Insulin neuroprotection against oxidative stress in cortical neurons - involvement of uric acid and glutathione antioxidant defenses. Free Radic Biol Med 39(7):876-889. doi: 10.1016/j.freeradbiomed.2005.05.002
45. Duarte AI, Santos P, Oliveira CR, Santos MS, Rego AC (2008) Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. Biochim Biophys Acta 1783(6):994-1002. doi: 10.1016/j.bbamcr.2008.02.016
46. Duarte AI, Moreira PI, Oliveira CR (2012) Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012:384017. doi: 10.1155/2012/384017
47. Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Placido A, Santos MS, Oliveira CR, Moreira PI (2013) Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta 1832(4):527-541. doi: 10.1016/j.bbadis.2013.01.008
48. Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7(Suppl 1):S29-S34. doi: 10.1038/sj.mp.4001016
49. El-Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A (1998) Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440(1-2):71-75. doi: 10.1016/S0014-5793(98)01418-5
50. El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 17(13):1945-1947. doi: 10.1096/fj.03-0098fje
51. Eldar-Finkelman H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8(3):126-132. doi: 10.1016/S1471-4914(01) 02266-3
52. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17(11):1143-1151. doi: 10.1097/00004647-199711000-00002
53. Fernandez AM, Torres-Aleman I (2012) The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 13(4):225-239. doi: 10.1038/nrn3209
54. Floyd RA, Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23(5):795-807. doi: 10.1016/S0197-4580(02)00019-2
55. Fort P, Imai H, Rajala R, Gardner T (2010) Insulin signaling in normal and diabetic conditions. In: Sitaramayya A (ed) Signal transduction: pathways, mechanisms and diseases. Springer Berlin Heidelberg, pp 101-118. doi: 10.1007/978-3-642-02112-1-6
56. Furuyama T, Nakazawa T, Nakano I, Mori N (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349(2):629-634. doi: 10.1042/0264-6021: 3490629
57. Gard PR (2008) Cognitive-enhancing effects of angiotensin IV. BMC Neuroscience 9(Suppl 2):S15. doi: 10.1186/1471-2202-9-S2-S15
58. Garelick MG, Kennedy BK (2011) TOR on the brain. Exp Gerontol 46(2-3):155-163. doi: 10.1016/j.exger.2010.08.030
59. Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21(8):2561-2570
60. + channels in mouse B cells. J Clin Investig 89(4):1288-1295. doi: 10.1172/jci115714
61. George JM (2002) The synucleins. Genome Biol 3(1):REVIEWS3002. doi: 10.1186/gb-2001-3-1-reviews3002
62. Gerozissis K (2008) Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol 585(1):38-49. doi: 10.1016/j.ejphar.2008.01.050
63. Ghosh HS, McBurney M, Robbins PD (2010) SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 5(2):e9199. doi: 10.1371/journal.pone. 0009199
64. Giese KP (2009) GSK-3: a key player in neurodegeneration and memory. IUBMB Life 61(5):516-521. doi: 10.1002/iub.187
65. Goldberg AL, St John AC (1976) Intracellular protein degradation in mammalian and bacterial cells: part 2. Annu Rev Biochem 45:747-803. doi: 10.1146/annurev.bi.45.070176.003531
66. Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P (2000) N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 859(2):286-292. doi: 10.1016/S0006-8993(00)01988-0
67. Guan QH, Pei DS, Zhang QG, Hao ZB, Xu TL, Zhang GY (2005) The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways. Brain Res 1035(1):51-59. doi: 10.1016/j.brainres.2004. 11.050
68. Guo W, Qian L, Zhang J, Zhang W, Morrison A, Hayes P, Wilson S, Chen T, Zhao J (2011) Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res 89(11):1723-1736. doi: 10.1002/jnr.22725
69. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92(10):4507-4511. doi: 10.1073/pnas.92.10.4507
70. Hales CN (1971) The role of insulin in the regulation of glucose metabolism. Proc Nutr Soc 30(3):282-288. doi: 10.1079/PNS19710054
71. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97(6):1634-1658. doi: 10.1111/j.1471-4159.2006.03907.x
72. Harbrecht BG, Nweze I, Smith JW, Zhang B (2012) Insulin inhibits hepatocyte iNOS expression induced by cytokines by an Akt-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 302(1):G116-G122. doi: 10.1152/ajpgi.00114.2011
73. Harrison LM, Lahoste GJ (2013) The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes. Exp Cell Res. doi: 10.1016/j.yexcr.2013.03.033
74. Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272(5656):827-829. doi: 10.1038/272827a0
75. Heales SJ, Bolanos JP (2002) Impairment of brain mitochondrial function by reactive nitrogen species: the role of glutathione in dictating susceptibility. Neurochem Int 40(6):469-474. doi: 10.1016/S0197-0186(01)00117-6
76. Herrera E, Jimenez R, Aruoma OI, Hercberg S, Sanchez-Garcia I, Fraga C (2009) Aspects of antioxidant foods and supplements in health and disease. Nutr Rev 67(Suppl 1):S140-S144. doi: 10.1111/j.1753-4887.2009.00177.x
77. Holcik M, Sonenberg N, Korneluk RG (2000) Internal ribosome initiation of translation and the control of cell death. Trends Genet 16(10):469-473. doi: 10.1016/S0168-9525(00)02106-5
78. Holscher C, van Aalten L, Sutherland C (2008) Anaesthesia generates neuronal insulin resistance by inducing hypothermia. BMC Neurosci 9:100. doi: 10.1186/1471-2202-9-100
79. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860-867. doi: 10.1038/nature05485
80. Hoyer S (2003) Memory function and brain glucose metabolism. Pharmacopsychiatry 36:S62-S67. doi: 10.1055/s-2003-40452
81. Hoyer S, Lannert H (2007) Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. J Neural Transm Suppl 72:195-202. doi: 10.1007/978-3-211-73574-9-25
82. Hui L, Pei DS, Zhang QG, Guan QH, Zhang GY (2005) The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation. Brain Res 1052(1):1-9. doi: 10.1016/j.brainres.2005.05.043
83. Inamura N, Nawa H, Takei N (2005) Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: implications for mammalian target of rapamycin signaling. J Neurochem 95(5):1438-1445. doi: 10.1111/j.1471-4159.2005.03466.x
84. Jafari Anarkooli I, Sankian M, Vahedi F, Bonakdaran S, Varasteh AR, Haghir H (2009) Evaluation of insulin and ascorbic acid effects on expression of Bcl-2 family proteins and caspase-3 activity in hippocampus of STZ-induced diabetic rats. Cell Mol Neurobiol 29(1):133-140. doi: 10.1007/s10571-008-9305-y
85. Jones RH, Shojaee-Moradie F (2002) Relationships between the structure of insulin and its physiological effects. In: Dieken M, Federwisch M, Meyts P (eds) Insulin and related proteins - structure to function and pharmacology. Springer Netherlands, pp 121-130. doi: 10.1007/0-306-47582-0-10
86. Joseph D'Ercole A, Ye P (2008) Expanding the mind: insulin-like growth factor I and brain development. Endocrinology 149(12):5958-5962. doi: 10.1210/en.2008-0920
87. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106(4):473-481. doi: 10.1172/JCI10842
88. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, Eimer S, Winklhofer KF, Haass C (2010) Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29(20):3571-3589. doi: 10.1038/emboj.2010.223
89. Kim SJ, Han Y (2005) Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt). J Neural Transm 112(2):179-191. doi: 10.1007/s00702-004-0163-6
90. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169-3179. doi: 10.1038/sj.emboj.7601758
91. Kita Y, Kimura KD, Kobayashi M, Ihara S, Kaibuchi K, Kuroda S, Ui M, Iba H, Konishi H, Kikkawa U, Nagata S, Fukui Y (1998) Microinjection of activated phosphatidylinositol-3 kinase induces process outgrowth in rat PC12 cells through the Rac-JNK signal transduction pathway. J Cell Sci 111(Pt 7):907-915
92. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275(5303):1132-1136. doi: 10.1126/science.2755303.1132
93. Konrad D, Rudich A, Klip A (2005) Insulin-mediated regulation of glucose metabolism. In: Insulin resistance. Wiley, pp 63-85. doi: 10.1002/0470011327.ch2
94. Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25(49):11288-11299. doi: 10.1523/JNEUROSCI.2284-05.2005
95. Lalic NM, Maric J, Svetel M, Jotic A, Stefanova E, Lalic K, Dragasevic N, Milicic T, Lukic L, Kostic VS (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65(4):476-480. doi: 10.1001/archneur.65.4.476
96. Lara-Castro C, Garvey WT (2004) Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab 89(9):4197-4205. doi: 10.1210/jc.2004-0683
97. Laron Z (2009) Insulin and the brain. Arch Physiol Biochem 115(2):112-116. doi: 10.1080/13813450902949012
98. Lawrence JC, Roach PJ (1997) New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46(4):541-547. doi: 10.2337/diabetes.46.4.541
99. Le Marchand-Brustel Y, Tanti JF, Cormont M, Ricort JM, Gremeaux T, Grillo S (1999) From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance. J Recept Signal Transduct Res 19(1-4):217-228. doi: 10.3109/10799899909036647
100. Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25(25):6016-6024. doi: 10.1523/JNEUROSCI.0692-05.2005
101. Lee CC, Huang CC, Hsu KS (2011) Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 61(4):867-879. doi: 10.1016/j.neuropharm.2011.06.003
102. LeRoith D (1983) CNS regulation of carbohydrate metabolism. In: Szabo A (ed) Advances in metabolic disorders, vol 10. Academic Press, London, pp 304-340
103. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4):479-489. doi: 10.1016/S0092-8674(00)80434-1
104. Li ZG, Zhang W, Grunberger G, Sima AA (2002) Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946(2):221-231. doi: 10.1016/S0006-8993(02)02887-1
105. Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56(7):1817-1824. doi: 10.2337/db07-0171
106. Li H, Liu B, Huang J, Chen H, Guo X, Yuan Z (2013) Insulin inhibits lipopolysaccharide-induced nitric oxide synthase expression in rat primary astrocytes. Brain Res 1506:1-11. doi: 10.1016/j.brainres.2013.01.055
107. Lim E, Lee S, Li E, Kim Y, Park S (2011) Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3beta pathways. Exp Neurol 230(1):114-122. doi: 10.1016/j.expneurol.2011.04.003
108. Liu P, Zou L, Jiao Q, Chi T, Ji X, Qi Y, Xu Q, Wang L (2013a) Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats. Neurosci Lett 543:115-120. doi: 10.1016/j.neulet.2013.02.065
109. Liu Y, Yao Z, Zhang L, Zhu H, Deng W, Qin C (2013b) Insulin induces neurite outgrowth via SIRT1 in SH-SY5Y cells. Neuroscience 238:371-380. doi: 10.1016/j.neuroscience.2013.01.034
110. Lu SC, Garcia-Ruiz C, Kuhlenkamp J, Ookhtens M, Salas-Prato M, Kaplowitz N (1990) Hormonal regulation of glutathione efflux. J Biol Chem 265(27):16088-16095
111. Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W, Donowitz M, Nagata E, Snyder SH (2003) Akt as a mediator of cell death. Proc Natl Acad Sci USA 100(20):11712-11717. doi: 10.1073/pnas.1634990100
112. Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2(7):554-565. doi: 10.1038/nrd1132
113. Martins JO, Ferracini M, Ravanelli N, Landgraf RG, Jancar S (2008) Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-kappaB activation in alveolar macrophages. Cell Physiol Biochem 22(1-4):279-286. doi: 10.1159/000149806
114. Maruyama W, Akao Y, Youdim MB, Davis BA, Naoi M (2001) Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem 78(4):727-735. doi: 10.1046/j.1471-4159.2001. 00448.x
115. Medina-Gomez G, Lelliott C, Vidal-Puig AJ (2005) Genetically modified mouse models of insulin resistance. In: Insulin resistance. Wiley, pp 133-153. doi: 10.1002/0470011327.ch5
116. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H (1993) The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48(4):M117-M121. doi: 10.1093/geronj/48.4.M117
117. Merry TL, McConell GK (2009) Skeletal muscle glucose uptake during exercise: a focus on reactive oxygen species and nitric oxide signaling. IUBMB Life 61(5):479-484. doi: 10.1002/iub.179
118. Metz HE, Houghton AM (2011) Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res 17(2):206-211. doi: 10.1158/1078-0432.CCR-10-0434
119. Miers WR, Barrett EJ (1998) The role of insulin and other hormones in the regulation of amino acid and protein metabolism in humans. J Basic Clin Physiol Pharmacol 9(2-4):235-253. doi: 10.1515/JBCPP.1998.9.2-4.235
120. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R, Karin M (1994) c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 14(10):6683-6688. doi: 10.1128/MCB.14.10.6683
121. Moncada S, Bolanos JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97(6):1676-1689. doi: 10.1111/j.1471-4159.2006. 03988.x
122. Moroo I, Yamada T, Makino H, Tooyama I, McGeer PL, McGeer EG, Hirayama K (1994) Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol 87(4):343-348. doi: 10.1007/BF00313602
123. Muller AP, Haas CB, Camacho-Pereira J, Brochier AW, Gnoatto J, Zimmer ER, de Souza DO, Galina A, Portela LV (2013) Insulin prevents mitochondrial generation of HO in rat brain. Exp Neurol 247C:66-72. doi: 10.1016/j.expneurol. 2013.03.007
124. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16(8):323-328. doi: 10.1016/0166-2236(93)90109-Y
125. Nakae J, Park BC, Accili D (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 274(23):15982-15985. doi: 10.1074/jbc.274.23.15982
126. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, Edwards RH (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 286(23):20710-20726. doi: 10.1074/jbc.M110.213538
127. Nemoto T, Satoh S, Maruta T, Kanai T, Yoshikawa N, Miyazaki S, Yanagita T, Wada A (2010) Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3 beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation. Neuropharmacology 58(7):1097-1108. doi: 10.1016/j.neuropharm.2010.01.018
128. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71(3):651-655. doi: 10.1086/342288
129. Nicolas O, Gavin R, Braun N, Urena JM, Fontana X, Soriano E, Aguzzi A, del Rio JA (2007) Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion. FASEB J 21(12):3107-3117. doi: 10.1096/fj.06-7827com
130. Niki E, Kawakami A, Saito M, Yamamoto Y, Tsuchiya J, Kamiya Y (1985) Effect of phytyl side chain of vitamin E on its antioxidant activity. J Biol Chem 260(4):2191-2196
131. Ning J, Hong T, Yang X, Mei S, Liu Z, Liu HY, Cao W (2011) Insulin and insulin signaling play a critical role in fat induction of insulin resistance in mouse. Am J Physiol Endocrinol Metab 301(2):E391-E401. doi: 10.1152/ajpendo.00164.2011
132. Offen D, Shtaif B, Hadad D, Weizman A, Melamed E, Gil-Ad I (2001) Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease. Neurosci Lett 316(3):129-132. doi: 10.1016/S0304-3940(01) 02344-8
133. Oh HI (2013) Fatty acid induced insulin resistance in the brain. Utah State University, Logan
134. Oliveras-Lopez MJ, Berna G, Carneiro EM, de la Serrana HLG, Martin F, Lopez MC (2008) An extra-virgin olive oil rich in polyphenolic compounds has antioxidant effects in of 1 mice. J Nutr 138(6):1074-1078
135. Pandini G, Pace V, Copani A, Squatrito S, Milardi D, Vigneri R (2013) Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 154(1):375-387. doi: 10.1210/En.2012-1661
136. Pangalos MN, Schechter LE, Hurko O (2007) Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 6(7):521-532. doi: 10.1038/nrd2094
137. Picillo M, Erro R, Santangelo G, Pivonello R, Longo K, Pivonello C, Vitale C, Amboni M, Moccia M, Colao A, Barone P, Pellecchia MT (2013) Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naive Parkinson's disease. J Neurol. doi: 10.1007/s00415-013-6851-0
138. Piwkowska A, Rogacka D, Angielski S, Jankowski M (2012) Hydrogen peroxide induces activation of insulin signaling pathway via AMP-dependent kinase in podocytes. Biochem Biophys Res Commun 428(1):167-172. doi: 10.1016/j.bbrc.2012. 10.033
139. Plum L, Schubert M, Bruning JC (2005) The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16(2):59-65. doi: 10.1016/j.tem.2005.01.008
140. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice - a model of familial Parkinson's disease. Neurobiol Dis 18(3):492-498. doi: 10.1016/j.nbd.2004.12.009
141. Qi S, Mizuno M, Yonezawa K, Nawa H, Takei N (2010) Activation of
142. Quesada A, Lee BY, Micevych PE (2008) PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol 68(5):632-644. doi: 10.1002/dneu.20609
143. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288(2):481-487. doi: 10.1016/0003-9861(91)90224-7
144. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50(5):567-575. doi: 10.1016/j.freeradbiomed.2010. 12.006
145. Ramadori G, Lee CE, Bookout AL, Lee S, Williams KW, Anderson J, Elmquist JK, Coppari R (2008) Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 28(40):9989-9996. doi: 10.1523/JNEUROSCI.3257- 08.2008
146. Ramalingam M, Kim SJ (2009) The protective effects of insulin on hydrogen peroxide-induced oxidative stress in C6 glial cells. Biomol Therap 17(4):395-402. doi: 10.4062/biomolther.2009.17.4.395
147. Ramalingam M, Kim SJ (2012) Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases. J Neural Transm 119(8):891-910. doi: 10.1007/s00702-011-0758-7
148. Ramrez M, Banegas I, Beln A, Wangesteen R, de M, Durn R, Vives F, Martnez A, Alba F, Prieto I (2012) Bilateral distribution of oxytocinase activity in the medial prefrontal cortex of spontaneously hypertensive rats with experimental hemiparkinsonism. In: Dushanova J (ed) Mechanisms in Parkinson's disease - models and treatments. InTech, Rijeka, pp 277-292. doi: 10.5772/17573
149. Razay G, Wilcock GK (1994) Hyperinsulinaemia and Alzheimer's disease. Age Ageing 23(5):396-399. doi: 10.1093/ageing/23.5.396
150. Reaven GM (1997) Banting lecture 1988. Role of insulin resistance in human disease. Nutrition 13(1):65. doi: 10.1016/S0899-9007(97)80637-5 (discussion 64, 66)
151. Reger MA, Watson GS, Frey WH 2nd, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S (2006) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27(3):451-458. doi: 10.1016/j.neurobiolaging.2005.03.016
152. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH 2nd, Craft S (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13(3):323-331
153. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P (1999) Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274(24):17179-17183. doi: 10.1074/jbc.274.24.17179
154. Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR, Cohen P (2002) Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 21(9):2263-2271. doi: 10.1093/emboj/21.9.2263
155. Sadagurski M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, Krainc D, White MF (2011) IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest 121(10):4070-4081. doi: 10.1172/JCI46305
156. Saha RN, Pahan K (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8(5-6):929-947. doi: 10.1089/ars.2006.8.929
157. Sakamoto J, Miura T, Shimamoto K, Horio Y (2004) Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett 556(1-3):281-286. doi: 10.1016/S0014-5793(03)01444-3
158. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96(4):1005-1015. doi: 10.1111/j.1471-4159.2005.03637.x
159. Schechter R, Whitmire J, Holtzclaw L, George M, Harlow R, Devaskar SU (1992) Developmental regulation of insulin in the mammalian central nervous system. Brain Res 582(1):27-37. doi: 10.1016/0006-8993(92)90313-X
160. Scheid MP, Woodgett JR (2001) PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2(10):760-768. doi: 10.1038/35096067
161. Schiekofer S, Galasso G, Andrassy M, Aprahamian T, Schneider J, Rocnik E (2006) Glucose control with insulin results in reduction of NF-kappaB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes. Diabetes Obes Metab 8(5):473-482. doi: 10.1111/j.1463-1326.2006.00524. x
162. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 24(8):855-872. doi: 10.1016/S0149-7634(00)00040-3
163. Schulz JB, Matthews RT, Beal MF (1995) Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol 8(6):480-486. doi: 10.1097/00019052-199512000-00016
164. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13(3):387-414. doi: 10.1210/edrv-13-3-387
165. Sechi LA (1999) Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens 17(9):1229-1237. doi: 10.1097/00004872-199917090-00001
166. Shacka JJ, Roth KA (2005) Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications. Curr Drug Targets CNS Neurol Disord 4(1):25-39. doi: 10.2174/1568007053005127
167. Shanik MH, Xu YP, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia is hyperinsulinemia the cart or the horse? Diabetes Care 31:S262-S268. doi: 10.2337/Dc08-S264
168. Shindler KS, Yunker AM, Cahn R, Zha J, Korsmeyer SJ, Roth KA (1998) Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro. Cell Death Differ 5(10):901-910. doi: 10.1038/sj.cdd.4400421
169. Shisheva A (2008) Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3. Am J Physiol Endocrinol Metab 295(3):E536-E544. doi: 10.1152/ajpendo.90353.2008
170. Sima AA, Li ZG (2005) The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54(5):1497-1505. doi: 10.2337/diabetes.54.5.1497
171. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144(2):281-292. doi: 10.1083/jcb.144.2.281
172. Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x
173. Stark R, Roden M (2007) ESCI award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Invest 37(4):236-248. doi: 10.1111/j.1365-2362. 2007.01773.x
174. Steiner DF, Oyer PE (1967) The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57(2):473-480. doi: 10.1073/pnas.57.2.473
175. Stockhorst U, de Fries D, Steingrueber HJ, Scherbaum WA (2004) Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav 83(1):47-54. doi: 10.1016/j.physbeh.2004.07.022
176. Stragier B, De Bundel D, Sarre S, Smolders I, Vauquelin G, Dupont A, Michotte Y, Vanderheyden P (2008) Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Fail Rev 13(3):321-337. doi: 10.1007/s10741-007-9062-x
177. Stranahan A, Mattson M (2010) Stress hormones and neuroplasticity in the diabetic brain. In: Craft S, Christen Y (eds) Diabetes, insulin and Alzheimer's disease. Research and perspectives in Alzheimer's disease. Springer Berlin Heidelberg, pp 57-71. doi: 10.1007/978-3-642-04300-0-4
178. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA (2007) Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117(4):910-918. doi: 10.1172/Jci30077
179. Suh HS, Zhao ML, Derico L, Choi N, Lee SC (2013) Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflamm 10:37. doi: 10.1186/1742-2094-10-37
180. Sung JY, Park SM, Lee CH, Um JW, Lee HJ, Kim J, Oh YJ, Lee ST, Paik SR, Chung KC (2005) Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J Biol Chem 280(26):25216-25224. doi: 10.1074/jbc.M503341200
181. Takahashi M, Yamada T, Tooyama I, Moroo I, Kimura H, Yamamoto T, Okada H (1996) Insulin receptor mRNA in the substantia nigra in Parkinson's disease. Neurosci Lett 204(3):201-204. doi: 10.1016/0304-3940(96)12357-0
182. Takeda S, Sato N, Rakugi H, Morishita R (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol Biol Syst 7(6):1822-1827. doi: 10.1039/c0mb00302f
183. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122(4):1316-1338. doi: 10.1172/JCI59903
184. Tremblay-Mercier J (2012) Peroxisome proliferator activated receptor alpha (PPARa) agonists: a potential tool for a healthy aging brain. In: Gallelli L (ed) Pharmacology. InTech, pp 123-140. doi: 10.5772/32056
185. Tully T, Bourtchouladze R, Scott R, Tallman J (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2(4):267-277. doi: 10.1038/nrd1061
186. Umegaki H (2013) Insulin resistance in the brain: a new therapeutic target for Alzheimer's disease. J Diabetes Investig 4(2):150-151. doi: 10.1111/jdi.12027
187. Unger J, McNeill TH, Moxley RT 3rd, White M, Moss A, Livingston JN (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31(1):143-157. doi: 10.1016/0306-4522(89)90036-5
188. Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36(5):343-362. doi: 10.1016/0301-0082(91)90015-S
189. Vazquez-Manrique R, Tourette C, Neri C (2013) Therapeutic potential of longevity modulators as neuroprotective targets in neurodegenerative disease. In: Morimoto RI, Christen Y (eds) Protein quality control in neurodegenerative diseases. research and perspectives in Alzheimer's disease. Springer Berlin Heidelberg, pp 111-120. doi: 10.1007/978-3-642-27928-7-9
190. Waxman EA, Giasson BI (2009) Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta 1792(7):616-624. doi: 10.1016/j.bbadis.2008.09.013
191. Williamson DH (1989) Role of insulin in the integration of lipid metabolism in mammalian tissues. Biochem Soc Trans 17(1):37-40. doi: 10.1042/bst0170037
192. Wu X, Reiter CE, Antonetti DA, Kimball SR, Jefferson LS, Gardner TW (2004) Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner. J Biol Chem 279(10):9167-9175. doi: 10.1074/jbc.M312397200
193. Wu D, Qiu Y, Gao X, Yuan XB, Zhai Q (2011) Overexpression of SIRT1 in mouse forebrain impairs lipid/glucose metabolism and motor function. PLoS One 6(6):e21759. doi: 10.1371/journal.pone.0021759
194. Yanagita T, Nemoto T, Satoh S, Yoshikawa N, Maruta T, Shiraishi S, Sugita C, Murakami M (2013) Neuronal insulin receptor signaling: a potential target for the treatment of cognitive and mood disorders. In: Kocabasoglu N (ed) Mood disorders. InTech, Rijeka, pp 263-288. doi: 10.5772/54389
195. Yang W, Leystra-Lantz C, Strong MJ (2008) Upregulation of GSK3beta expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci). Brain Res 1196:131-139. doi: 10.1016/j.brainres.2007.12.031
196. Yao HB, Shaw PC, Wong CC, Wan DC (2002) Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J Chem Neuroanat 23(4):291-297. doi: 10.1016/S0891-0618(02)00014-5
197. Yin F, Boveris A, Cadenas E (2012) Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal. doi: 10.1089/ars.2012.4774
198. Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407(6805):802-809. doi: 10.1038/35037739
199. Zadori D, Nyiri G, Szonyi A, Szatmari I, Fulop F, Toldi J, Freund TF, Vecsei L, Klivenyi P (2011) Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease. J Neural Transm 118(6):865-875. doi: 10.1007/s00702-010-0573-6
200. Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263(5147):687-689. doi: 10.1126/science.8080500
201. Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177(1-2):125-134. doi: 10.1016/S0303-7207(01) 00455-5
202. Zhu W, Bijur GN, Styles NA, Li X (2004) Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res 126(1):45-56. doi: 10.1016/j.molbrainres.2004.03. 019